Precision Medicine News and Research

RSS

Using supercomputers to screen drugs for deadly heart arrhythmias

Death from sudden cardiac arrest makes headlines when it strikes athletes. But it also causes the most deaths by natural causes in the U.S. estimated at 325,000 per year.

14 May 2020

Regeneron and CCPM collaborate to advance human genetics, precision medicine

Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine at the University of Colorado Anschutz Medical Campus today announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine through the sharing of 450,000 DNA samples and corresponding health records from de-identified, consented patient participants in the expansive UCHealth system.

11 May 2020

The nutritional key to control autoimmunity and cancer

Scientists at the Department of Infection and Immunity of the Luxembourg Institute of Health revealed a novel mechanism through which the immune system can control autoimmunity and cancer.

8 May 2020

New study may facilitate personalized therapy for depression, other neurological disorders

Depression is the leading cause of disability worldwide, striking as many as one in four women and one in eight men in their lifetime.

5 May 2020

Individuals with high risk of cancer and CVD cannot be identified based on family history

Certain genetic changes, termed "pathogenic variants," substantially increase risk for cardiovascular disease and cancer--the leading causes of death--but testing to identify individual carriers is not part of current clinical practice.

4 May 2020

AHA awards grants to 12 teams for fast-tracked heart and brain health research related to COVID-19

Less than a month after issuing a rapid response call for scientific research proposals for fast-tracked studies of the effects of COVID-19 on the body's cardiovascular and cerebrovascular systems, the American Heart Association has awarded $1.2 million in grants to teams at 12 institutions across the U.S. to begin this unprecedented work.

2 May 2020

Gustave Roussy and Biognosys Announce Partnership

The severe pneumonitis in patients infected by SARS-Cov-2 requires prolonged treatment in intensive care units with mechanical ventilation.

From Biognosys 28 Apr 2020

Investigational drug may hold benefit for patients with lung and ovarian cancers

In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.

27 Apr 2020

Study: Effective integration of diverse scientific disciplines is vital to address scientific problems

Announcing a new article publication for BIO Integration journal. In this commentary article the authors Phei Er Saw and Shanping Jiang from Sun Yat-sen University, Guangzhou, People's Republic of China consider the significance of interdisciplinary integration in academic research and application.

23 Apr 2020

Emergex partners with George Mason University for highly pathogenic RNA virus studies

Emergex Vaccines Holding Limited, a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, today announced that it has entered into an agreement with the George Mason University, based in Virginia, in the United States.

22 Apr 2020

Making long-term research project a translational success

The Digital Health Accelerator (DHA) of the Berlin Institute of Health (BIH) is helping the scientists to make the long-term research project a translational success.

22 Apr 2020

FDA approves new Rutgers saliva test for coronavirus

The FDA has granted emergency use authorization to Rutgers' RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency.

13 Apr 2020

Mount Sinai launches web-based app to capture symptoms, spread of COVID-19 in New York City

A team of data scientists, physicians, and engineers across the Mount Sinai Health System has come together to launch STOP COVID NYC, a web-based app to capture the symptoms and spread of COVID-19 in New York City--currently the epicenter of the nation's largest outbreak.

6 Apr 2020

Study proposes method to extend polygenic scores to individuals with mixed ancestry

A new study in Nature Communications proposes a method to extend polygenic scores, the estimate of genetic risk factors and a cornerstone of the personalized medicine revolution, to individuals with multiple ancestral origins.

2 Apr 2020

UVA researchers find way to enhance cancer outcomes by examining patients' genetic data

By mining a vast trove of genetic data, researchers at the University of Virginia School of Medicine are enhancing doctors’ ability to treat cancer, predict patient outcomes and determine which treatments will work best for individual patients.

30 Mar 2020

Study finds promising biomarker for diagnosis of schizophrenia and treatment response

Around four in a thousand people worldwide suffer from schizophrenia, according to scientific estimates. The disease affects people from all walks of life, including Vincent van Gogh, the painter Agnes Martin, mathematician John Nash and Eduard Einstein, a son of the great physicist. The disease touches men and women equally.

23 Mar 2020

Precision Medicine News and Research

Using supercomputers to screen drugs for deadly heart arrhythmias

Regeneron and CCPM collaborate to advance human genetics, precision medicine

The nutritional key to control autoimmunity and cancer

New study may facilitate personalized therapy for depression, other neurological disorders

Individuals with high risk of cancer and CVD cannot be identified based on family history

AHA awards grants to 12 teams for fast-tracked heart and brain health research related to COVID-19

Gustave Roussy and Biognosys Announce Partnership

Investigational drug may hold benefit for patients with lung and ovarian cancers

Study: Effective integration of diverse scientific disciplines is vital to address scientific problems

Emergex partners with George Mason University for highly pathogenic RNA virus studies

Making long-term research project a translational success

FDA approves new Rutgers saliva test for coronavirus

Mount Sinai launches web-based app to capture symptoms, spread of COVID-19 in New York City

Study proposes method to extend polygenic scores to individuals with mixed ancestry

UVA researchers find way to enhance cancer outcomes by examining patients' genetic data

Study finds promising biomarker for diagnosis of schizophrenia and treatment response

Overview of prognostic and predictive factors in pancreatic cancer

New collapsible basket technology has big advantages for drug discovery, personalized medicine

Personalized approach in IVF increases success rate

Challenges for translating pharmacomicrobiomics to personalized medicine

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News